Sun Pharmaceutical Industries Share Price Today - Live Blog for December 15, 2025

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.22% decline and is currently trading at ₹1,794.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

With a remarkable 0.09% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,797.30. Notably, this stock has a Price-to-Earnings (PE) ratio of 41.0600, while the industry's PE ratio is 33.2891.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.09% uptick, and they are currently valued at ₹1,794.10, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.09%. At this moment, it's actively trading at ₹1,794.10, presenting an enticing opportunity for those in the market.

With a -0.01% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,792.40. Investors should examine the factors driving this decline. The stock's PE ratio is 41.0600, whereas the industry PE ratio stands at 33.2891.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.01% slump and is currently trading at ₹1,792.40. While the stock maintains a PE ratio of 41.0600, the industry PE is 33.2891, raising questions about valuation.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.49%, with the current market value at ₹1,789.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.49%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,789.50, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd observed a -0.06% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,797.50. The stock has a PE ratio of 41.0600, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.06% gain, with the share price now at ₹1,798.00. Notably, the stock's PE ratio stands at 41.0600, and its Return on Equity (ROE) is 14.8407%.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.03% in its share price, and it currently trades at ₹1,797.00 per share. The stock has an ROE of 14.8407% and debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.05%, reaching the current market value of ₹1,798.60 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd share price surged by 0.03%. With its current market price standing at ₹1,797.15 per share, this stock is garnering increased attention from the investment community.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.03%, reaching the current market price of ₹1,796.60. This surge is indicative of the stock's recent positive performance.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.04% increase. Presently, it is actively trading at ₹1,797.25.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.14% surge in its share price and is presently trading at ₹1,796.00. The increased investor interest is driving this surge.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.29% gain, with the share price now at ₹1,793.55. Notably, the stock's PE ratio stands at 41.0600, and its Return on Equity (ROE) is 14.8407%.

After a significant 0.11% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,786.75 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.04% uptick in its share price. As a result, it's now actively trading at ₹1,785.30 per share, making it an attractive option for investors.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.04% slump and is currently trading at ₹1,784.50. While the stock maintains a PE ratio of 41.0600, the industry PE is 33.2891, raising questions about valuation.

Sun Pharmaceutical Industries Ltd witnessed a -0.04% decrease in its share price, and it is currently trading at ₹1,784.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 41.0600, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd share price surged by 0.40%. With its current market price standing at ₹1,785.25 per share, this stock is garnering increased attention from the investment community.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.40%, reaching the current market price of ₹1,785.25. This surge is indicative of the stock's recent positive performance.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.20%, with the current market value at ₹1,779.20 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.20%, reaching a current market price of ₹1,779.20. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.20%, with the current market value at ₹1,779.20 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

After a significant 0.02% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,782.75 in the current market. This upward movement is attracting attention from both retail and institutional investors.

With a -0.03% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,781.20. Investors should examine the factors driving this decline. The stock's PE ratio is 41.0600, whereas the industry PE ratio stands at 33.2891.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -0.06% drop, and it's now trading at ₹1,780.10 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Sun Pharmaceutical Industries Ltd experienced a -0.06% downturn in its share price, and it's currently trading at ₹1,780.10. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.73%, signalling a challenging period. Currently trading at ₹1,780.80, this stock has caught the eye of bargain hunters, who may be considering their entry points.